Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence GDSTFESKSY
Primary information
sequence IDSeq_2564
Peptide sequenceGDSTFESKSY
CancerPDF_ID CancerPDF_ID1214, CancerPDF_ID2283, CancerPDF_ID9660,
PMID21136997,21136997,21533267
Protein NameFibrinogen alpha,Fibrinogen alpha,Fibrinogen alpha chain
UniprotKB Entry NameFIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN
FluidSerum,Plasma,Serum
M/Z1119.47203,1119.472,560.73
Charge1,1,2
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueLC-MS-MS/MS,LC-MS-MS/MS,LC/MS/MS
Quantification TechniqueLC-ESI-MS,LC-ESI-MS,Multiple Reaction Monitoring
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,NA,1.49
CancerPDF_ID CancerPDF_ID1214, CancerPDF_ID2283, CancerPDF_ID9660,
p-ValueNA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT
Length10,10,10
Cancer TypeColorectal cancer,Normal,Lung adenocarcinoma
DatabaseSwissProt Database,SwissProt Database,Swissprot Database (57.4)
ModificationNA,NA,NA
Number of Patients30 patients and 30 healthy controls,27 healthy individuals,62 lung adenocarcinoma and 30 healthy control
RegulationNA,NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal"
ValidationLeave One out Cross validation,Leave One out Cross validation,MRM-based validation of 19 candidates
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB139616